Maxpride 200 Tablet contains Amisulpride 200 mg, an atypical antipsychotic agent primarily indicated for the treatment of schizophrenia and other psychotic disorders. Amisulpride acts selectively on dopamine D2 and D3 receptors, exerting its therapeutic effects by modulating dopaminergic neurotransmission in the central nervous system. This action helps alleviate both positive symptoms such as hallucinations and delusions, as well as negative symptoms including social withdrawal and apathy. Maxpride 200 is typically prescribed for adults and should be administered under strict medical supervision, with dosage individualized based on clinical response and tolerability. Common side effects may include extrapyramidal symptoms, hyperprolactinemia, insomnia, and gastrointestinal disturbances. Caution is advised in patients with a history of cardiac disorders, as amisulpride can prolong the QT interval, increasing the risk of arrhythmias. Regular monitoring of cardiac function, blood counts, and metabolic parameters is recommended during prolonged therapy. Maxpride 200 should not be abruptly discontinued to avoid withdrawal symptoms or relapse. It is contraindicated in patients with hypersensitivity to amisulpride, severe renal impairment, or concomitant use of other QT-prolonging drugs. This medication should be stored at room temperature, away from moisture and direct sunlight, and kept out of reach of children.